Compare JNJ & MA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JNJ | MA |
|---|---|---|
| Founded | 1886 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 483.7B |
| IPO Year | 2003 | 2005 |
| Metric | JNJ | MA |
|---|---|---|
| Price | $255.62 | $614.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 40 |
| Target Price | $279.41 | ★ $671.23 |
| AVG Volume (30 Days) | ★ 6.8M | 2.6M |
| Earning Date | 10-13-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.12% | 0.56% |
| EPS Growth | ★ 90.50 | 18.93 |
| EPS | 4.41 | ★ 9.32 |
| Revenue | N/A | ★ $32,791,000,000.00 |
| Revenue This Year | $7.46 | $13.66 |
| Revenue Next Year | $6.60 | $12.61 |
| P/E Ratio | ★ $57.51 | $66.14 |
| Revenue Growth | N/A | ★ 16.42 |
| 52 Week Low | $184.66 | $464.52 |
| 52 Week High | $281.07 | $619.80 |
| Indicator | JNJ | MA |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 73.82 |
| Support Level | $247.97 | $551.76 |
| Resistance Level | $274.01 | N/A |
| Average True Range (ATR) | 5.46 | 9.63 |
| MACD | -0.74 | 5.97 |
| Stochastic Oscillator | 37.46 | 89.49 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Mastercard is the second-largest payment processor in the world, having processed close to $11 trillion in volume during 2025. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.